TY - JOUR T1 - Meta analysis of microbiome studies identifies shared and disease-specific patterns JF - bioRxiv DO - 10.1101/134031 SP - 134031 AU - Claire Duvallet AU - Sean Gibbons AU - Thomas Gurry AU - Rafael Irizarry AU - Eric Alm Y1 - 2017/01/01 UR - http://biorxiv.org/content/early/2017/05/08/134031.abstract N2 - Hundreds of clinical studies have been published that demonstrate associations between the human microbiome and a variety of diseases. Yet, fundamental questions remain on how we can generalize this knowledge. For example, if diseases are mainly characterized by a small number of pathogenic species, then new targeted antimicrobial therapies may be called for. Alternatively, if diseases are characterized by a lack of healthy commensal bacteria, then new probiotic therapies might be a better option. Results from individual studies, however, can be inconsistent or in conflict, and comparing published data is further complicated by the lack of standard processing and analysis methods.Here, we introduce the MicrobiomeHD database, which includes 29 published case-control gut microbiome studies spanning ten different diseases. Using standardized data processing and analyses, we perform a comprehensive crossdisease meta-analysis of these studies. We find consistent and specific patterns of disease-associated microbiome changes. A few diseases are associated with many individual bacterial associations, while most show only around 20 genus-level changes. Some diseases are marked by the presence of pathogenic microbes whereas others are characterized by a depletion of health-associated bacteria. Furthermore, over 60% of microbes associated with individual diseases fall into a set of “core” health and disease-associated microbes, which are associated with multiple disease states. This suggests a universal microbial response to disease. ER -